Digestive Disease Week DDW 2026

Include:  Videos

Target Audience: gastroenterologists, hepatologists, general surgeons, oncologists, bariatric specialists, allergists, and internal medicine physicians

Information:

Digestive Disease Week® (DDW) 2026 is one of the premier global forums in gastroenterology, hepatology, endoscopy, and GI surgery. The 2026 program introduces a significant shift toward a unified, content track-first approach, fostered collaboratively by its four participating societies: AASLD, AGA, ASGE, and SSAT. The event brings together over 13,000 attendees and focuses heavily on integrating AI-enabled diagnostics, personalizing care, and moving beyond isolated drug trials toward integrated models of clinical practice. Key scientific areas of focus include inflammatory bowel disease (IBD), eosinophilic esophagitis (EoE), digestive oncology, metabolic dysfunction-associated steatotic liver disease (MASLD), and advanced endoscopic systems.

Learning Objectives

Upon completion of this course, participants will be able to:

• Evaluate the current and potential applications of artificial intelligence in endoscopic practice, histology, and IBD severity assessment.

• Apply updated, evidence-based strategies to the endoscopic management of acute GI bleeding, pancreatobiliary diseases, and complex colorectal polyps.

• Incorporate noninvasive tools (NITs) to optimize the diagnosis, staging, and monitoring of MASH/MASLD, and select appropriate treatments such as resmetirom or GLP-1 RAs.

• Assess and select early-intervention therapies, combination treatments, and treat-to-target strategies to manage Inflammatory Bowel Disease (IBD) effectively.

• Evaluate emerging endoscopic and surgical treatments for obesity-related GI diseases, including endobariatrics and Endoscopic Sleeve Gastroplasty (ESG).

Target Audience

This educational activity is intended for gastroenterologists, hepatologists, surgeons, basic scientists, nurse practitioners, physician assistants, and nurses who are involved in the management of digestive and liver diseases.

Best for gastroenterologists, hepatologists, general surgeons, oncologists, bariatric specialists, allergists, and internal medicine physicians.

Topics

* WARNING: The main topics are summarized below; there are 403 topics in total.

• The Impact of AI on the Endoscopic Practice in Gastroenterology: Hype and Reality

• AI-Enabled Diagnostics and Intestinal Ultrasound in IBD Monitoring

• Eosinophilic Esophagitis (EoE): New Targeted Immunology and Epithelial Cytokines

• Early Intervention and Combination Therapies in Crohn’s Disease and Ulcerative Colitis

• Endobariatrics and ESG: Integration within a Multidisciplinary Model

• Advances in Colon Polyp Detection and Endoscopic vs. Surgical Resection

• Innovations and Updates in Pancreato-Biliary Endoscopy

• EUS-Guided Gallbladder Drainage with AXIOS™ Stent

• Diagnosis, Staging, and Management of MASH and MASLD

• Systemic Inflammation and Organ Failure in Acute Pancreatitis

• Tumor Immune Microenvironment in Colorectal Liver Metastases

• Pharmacological and Psychological Approaches to Disorders of Gut-Brain Interaction (DGBI)

• Updates in Hepatitis B and C Management and Care Delivery

• Modern Surgical Strategies Against Pancreatic Cancer

• Evolving Technologies: Robotic Scope Control and Suture-Based Innovation